SCHEMBL26631657

SCHEMBL26631657

Nc1nc(C(F)(F)F)ccc1-c1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.44
▸ TDO2 P48775 1/20 0.44
▸ CYP3A4 P08684 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ CFTR P13569 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ CYP11B1 P15538 3/20 0.41
▸ CYP17A1 P05093 2/20 0.41
▸ CYP11B2 P19099 2/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28619873 0.79 CYP11B1 (0.48) TDO2CYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL20449081 0.78 CYP2A6 (0.53) TDO2CYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL29202394 0.78 RAB9A (0.47) PTGS2CYP3A4ALDH1A1CFTRKDM4E
SCHEMBL17336612 0.76 CYP2A6 (0.51) TDO2CYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL3135642 0.73 CYP11B1 (0.46) CYP3A4ALDH1A1CYP1A2CYP2A6CYP11B1
SCHEMBL25222544 0.73 MAP4K4 (0.50) CYP3A4CA2
SCHEMBL30112165 0.73 MAP4K4 (0.50) CYP3A4CA2
SCHEMBL30627140 0.72 CYP2A6 (0.57) PTGS2CYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL1927394 0.72 GLA (0.58) TDO2CYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL15989428 0.72 CYP11B1 (0.53) TDO2CFTRCYP11B1CYP11B2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273146-A1 TRICYCLIC COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2023-11-08 — — EP disclosed
Send feedback